share_log

D. Boral Capital Initiates Coverage On Context Therapeutics With Buy Rating, Announces Price Target of $9

D. Boral Capital Initiates Coverage On Context Therapeutics With Buy Rating, Announces Price Target of $9

D. Boral Capital發起對Context Therapeutics的覆蓋,給予買入評級,宣佈目標股價爲9美元
Benzinga ·  2024/11/25 07:53  · 評級/大行評級

D. Boral Capital analyst Jason Kolbert initiates coverage on Context Therapeutics (NASDAQ:CNTX) with a Buy rating and announces Price Target of $9.

D. Boral Capital 分析師 Jason Kolbert 開始對 Context Therapeutics (納斯達克:CNTX) 進行覆蓋,給予買入評級,並宣佈價格目標爲9美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論